Sodium-glucose cotransporter 2 (SGLT2) mediates approximately 80–90% of renal glucose reabsorption under normal physiologic conditions, and SGLT2i can reduce 30–50% of the filtered glucose load in T2DM patients by increasing urinary glucose excretion [41]. The gene discussed is SLC5A2; the disease is type 2 diabetes mellitus.